ViaLase

ViaLase, Inc. is a clinical-stage medical technology company developing a noninvasive femtosecond laser treatment for glaucoma. Their ViaLase Laser aims to improve the current treatment paradigm by offering enhanced precision and visibility during trabecular meshwork procedures. This innovative approach has the potential to elevate the standard of care for glaucoma patients.

Buy Funded Startups lists

Funding Round: Series C

Funding Amount: $40M

Date: 01-Apr-2024

Investors: Venture Investors Health Fund, Arboretum Ventures, Falcon Vision, KKR

Markets: Medical Technology, Ophthalmology, Health Care, Medical Device, Wellness

HQ: Corona Del Mar, California, United States

Founded: 2019

Website: https://www.vialase.com/

LinkedIn: https://www.linkedin.com/company/vialase

Twitter:

Instagram: